Enhance MD vs RxActivate: Pricing, access, and plan differences
The Enhance MD vs RxActivate comparison centers on how each provider handles pricing transparency, compound options, intake gating, clinician review, and scale of membership. Quick verdict: Enhance MD is most notable for explicit low introductory prices and flat-rate dose pricing; RxActivate focuses on clinician-matched plans with pricing gated behind an eligibility and contact-information step.
Start with Enhance MD pricing and options
Price transparency and introductory offers
Enhance MD publishes introductory prices: semaglutide from $49 and tirzepatide from $99 for the first month, and emphasizes flat-rate pricing that stays the same at every dose with no escalation. RxActivate does not display price or billing terms before users complete an eligibility questionnaire and submit name, email, and phone number; pricing is gated behind intake.
See Enhance MD first-month pricing
Compound options and regulatory notes
Both providers operate clinician-reviewed telehealth models and may offer compounded medications. Enhance MD explicitly offers both compounded semaglutide and compounded tirzepatide on one platform. RxActivate requires eligibility confirmation before revealing plans and does not publish medication specifics prior to intake. Both sources include the regulatory qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
Intake flow, eligibility, and state screening
RxActivate routes users through a two-minute eligibility questionnaire that asks goal, height, weight, medication history, sex assigned at birth, date of birth, state, and safety screening; a synthetic test confirmed Alabama as serviceable. The flow displays likely eligibility and then requires contact information before any price or plan details are shown. Enhance MD provides pricing details up front, with clinician-directed review noted for treatment appropriateness.
Check RxActivate eligibility flow
Scale and experience
Enhance MD reports treating 10,000+ patients, which the source cites as meaningful clinical volume. RxActivate’s page states 250,000+ members in its flow. These are provider-published figures captured in the source materials and are not presented here as independent outcome evidence.
Direct comparison table
| Criterion | Enhance MD | RxActivate |
|---|---|---|
| Starting price shown | Semaglutide from $49; Tirzepatide from $99 first month | No price displayed before contact-information step |
| Ongoing pricing model | Flat-rate pricing: same price at every dose, no escalation | Pricing subject to clinician review and gated by intake |
| Compound availability | Offers compounded semaglutide and tirzepatide on one platform | Medication specifics not revealed before eligibility |
| Intake and eligibility | Clinician-directed review; pricing published upfront | Two-minute eligibility questionnaire; state and medical-safety screening; contact info required to view price |
| Scale reported | 10,000+ patients treated | 250,000+ members stated |
| Regulatory note | Compounded medications not FDA-approved | Compounded medications not FDA-reviewed; medication approval status must be confirmed |
What this means for patients
If you prioritize upfront cost visibility and the ability to choose between semaglutide and tirzepatide on a single platform, Enhance MD’s published introductory prices and flat-rate dosing model are the distinguishing facts from the source. If you prefer to complete a clinician-matching eligibility flow and confirm plan details only after intake, RxActivate’s gated questionnaire and state screening are the notable features.
Start RxActivate eligibility quiz
Clinician review and safety screening
Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate. RxActivate emphasizes clinician-matched plans and a state and medical-safety screening in its eligibility flow. Enhance MD notes clinician-directed prescribing alongside its pricing statements.
Conclusion: Enhance MD vs RxActivate
Enhance MD stands out for explicit low introductory pricing and flat-rate, same-price-at-every-dose messaging, plus on-platform access to both semaglutide and tirzepatide. RxActivate emphasizes a gated eligibility flow with clinician matching and state-level screening before disclosing plan or price. Both note that compounded medications are not FDA-approved.
Choose Enhance MD if you want visible starting prices (semaglutide from $49, tirzepatide from $99 first month), transparent flat-rate dose pricing, and access to both compounds on one platform.
Choose RxActivate if you prefer to confirm eligibility, state availability, and clinician-matched plan details before learning pricing and commitments.